Subscribe
Newsday – 2021 IT Predictions, Trends, Advice and a Tribute to my Father-in-law

This Week In Health IT

Newsday – 2021 IT Predictions, Trends, Advice and a Tribute to my Father-in-law

January 4, 2021

Newsday – 2021 IT Predictions, Trends, Advice and a Tribute to my Father-in-law

January 4, 2021: What are health leaders predicting for 2021? Welcome to a future where the patient, not the site of care is at the center. This is healthcare’s Amazon moment. Can you provide a seamless patient experience? Keep up or you could end up out of business. COVID-19 has reshaped our technology culture and policy. What used to take a decade can now be done in days. Look out because 2030 is going to arrive in 2021. Plus what my incredible father-in-law taught me about life … and healthcare.

Key Points:

  • Looking from the patient perspective and the family perspective helps us to see how our work is really impacting people [00:11:35] 
  • Simplify. Modernize. Innovate. [00:14:50] 
  • Walmart’s retail exposure in remote communities enables it to scale developing markets, lower consumer healthcare costs and expand access to primary and urgent care [00:21:10]
  • It’s important for the healthcare industry to recognize that AI algorithms trained on insufficiently diverse data can lead to AI bias [00:23:15] 
  • We know that social determinants of health play a critical role in health outcomes [00:25:05] 
  • Have systems really thought through building and maintaining culture across a virtual environment? [00:30:35] 
  • Focus was the key word in 2020. In 2021, our focus will get even more fine tuned. [00:32:00] 
  • One of the most helpful technologies to engage patients on their journey is the use of real time information [00:32:15] 

Story:

You may also like

Subscribe to Health Podcast Network

Proudly supported by:

cover
Hera Diagnostics is eradicating cervical cancer in developing communities Teo Tijerina is the CEO of Hera Medical Devices, a cancer diagnostics startup currently focusing on bringing a cervical cancer screening tool to market.